PDF herunterladen
CC BY-NC-ND 4.0 · AJP Rep 2024; 14(01): e22-e25
DOI: 10.1055/s-0043-1777998
Case Report

Small Cell Cervical Carcinoma in Pregnancy: Therapeutic Options for an Aggressive Cancer Diagnosis

Alyssa Savelli Binsted 
1   Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, Virginia
,
Zeinab Kassem
1   Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, Virginia
,
David Le 
1   Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, Virginia
,
Margarita de Veciana
1   Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Norfolk, Virginia
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Abstract

Neuroendocrine small cell cervical carcinoma is an aggressive cancer which accounts for approximately 1 to 3% of all cervical neoplasms. Therapy must be altered in pregnancy to optimize maternal–fetal outcomes. A 39-year-old woman presented for a routine prenatal visit and was noted to have a grossly abnormal cervix. Cervical biopsies confirmed small cell carcinoma. At 19 weeks' gestation, chemotherapy was initiated. The patient delivered at 34 weeks' gestation to initiate radiation therapy. Six months later, she was diagnosed with metastatic disease and died from cancer complications. In pregnancy, treatment modalities for small cell cervical carcinoma are based on the patient's gestational age at diagnosis. While aggressive early treatment is preferred, platinum-based chemotherapy can be initiated in the second trimester and radiation therapy delayed until delivery. Small cell cervical carcinoma complicating pregnancy requires aggressive treatment. Chemotherapy in the second trimester with planned delayed radiation therapy, may optimize fetal outcomes.

Keywords

small cell carcinoma - cervical cancer in pregnancy - small cell cervical carcinoma in pregnancy - management - small cell cervical cancer - therapy


Publikationsverlauf

Eingereicht: 31. Dezember 2020

Angenommen: 22. Oktober 2023

Artikel online veröffentlicht:
23. Januar 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Delaloge S, Pautier P, Kerbrat P. et al. Neuroendocrine small cell carcinoma of the uterine cervix: what disease? What treatment? Report of ten cases and a review of the literature. Clin Oncol (R Coll Radiol) 2000; 12 (06) 357-362
    CrossrefPubMedGoogle Scholar
  • 2 Gardner GJ, Reidy-Lagunes D, Gehrig PA. Neuroendocrine tumors of the gynecologic tract: a Society of Gynecologic Oncology (SGO) clinical document. Gynecol Oncol 2011; 122 (01) 190-198
    CrossrefPubMedGoogle Scholar
  • 3 Liao LM, Zhang X, Ren YF. et al. Chromogranin A (CgA) as poor prognostic factor in patients with small cell carcinoma of the cervix: results of a retrospective study of 293 patients. PLoS One 2012; 7 (04) e33674
    CrossrefPubMedGoogle Scholar
  • 4 Ohwada M, Suzuki M, Hironaka M, Irie T, Sato I. Neuroendocrine small cell carcinoma of the uterine cervix showing polypoid growth and complicated by pregnancy. Gynecol Oncol 2001; 81 (01) 117-119
    CrossrefPubMedGoogle Scholar
  • 5 Pan L, Liu R, Sheng X, Chen D. Small cell neuroendocrine carcinoma of the cervix in pregnancy: a case report and review. Case Rep Obstet Gynecol 2019; 8028459
    PubMedGoogle Scholar
  • 6 Teefey P, Orr B, Vogt M, Roberts W. Neuroendocrine carcinoma of the cervix during pregnancy: a case report. Gynecol Oncol Case Rep 2012; 2 (03) 73-74
    CrossrefPubMedGoogle Scholar
  • 7 Cohen JG, Kapp DS, Shin JY. et al. Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients. Am J Obstet Gynecol 2010; 203 (04) 347.e1-347.e6
    CrossrefPubMedGoogle Scholar
  • 8 English DP, Roque DM, Carrara L. et al. HER2/neu gene amplification determines the sensitivity of uterine serous carcinoma cell lines to AZD8055, a novel dual mTORC1/2 inhibitor. Gynecol Oncol 2013; 131 (03) 753-758
    CrossrefPubMedGoogle Scholar
  • 9 McCusker ME, Coté TR, Clegg LX, Tavassoli FJ. Endocrine tumors of the uterine cervix: incidence, demographics, and survival with comparison to squamous cell carcinoma. Gynecol Oncol 2003; 88 (03) 333-339
    CrossrefPubMedGoogle Scholar
  • 10 Morris M, Gershenson DM, Eifel P, Silva EG, Mitchell MF, Burke TW, Wharton JT. Treatment of small cell carcinoma of the cervix with cisplatin, doxorubicin, and etoposide. Gynecol Oncol 1992; 47 (01) 62-65 DOI: 10.1016/0090-8258(92)90077-v. . PMID: 1330847
    CrossrefPubMedGoogle Scholar
  • 11 Li JD, Zhuang Y, Li YF. et al. A clinicopathological aspect of primary small-cell carcinoma of the uterine cervix: a single-centre study of 25 cases. J Clin Pathol 2011; 64 (12) 1102-1107
    CrossrefPubMedGoogle Scholar
  • 12 Masumoto N, Fujii T, Ishikawa M. et al. P16 overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervix. Hum Pathol 2003; 34 (08) 778-783
    CrossrefPubMedGoogle Scholar
  • 13 Lee JM, Lee KB, Nam JH. et al. Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study. Ann Oncol 2008; 19 (02) 321-326
    CrossrefPubMedGoogle Scholar
  • 14 Nagao S, Miwa M, Maeda N. et al. Clinical features of neuroendocrine carcinoma of the uterine cervix: a single-institution retrospective review. Int J Gynecol Cancer 2015; 25 (07) 1300-1305
    CrossrefPubMedGoogle Scholar
  • 15 Leitao M, Zivanovic O. Small cell neuroendocrine carcinoma of the cervix. In: Post TW, ed. Waltham, MA: UpToDate; 2020
    Google Scholar
  • 16 Balderston KD, Tewari K, Gregory WT, Berman ML, Kucera PR. Neuroendocrine small cell uterine cervix cancer in pregnancy: long-term survival following combined therapy. Gynecol Oncol 1998; 71 (01) 128-132
    CrossrefPubMedGoogle Scholar
  • 17 Wang Q, Liu YH, Xie L, Hu WJ, Liu BR. Small cell carcinoma of the uterine cervix in pregnancy: a case report and review of the literature. Oncol Lett 2015; 9 (01) 91-95
    CrossrefPubMedGoogle Scholar
  • 18 Mir O, Berveiller P, Ropert S, Goffinet F, Goldwasser F. Use of platinum derivatives during pregnancy. Cancer 2008; 113 (11) 3069-3074
    CrossrefPubMedGoogle Scholar
  • 19 Chen J, Macdonald OK, Gaffney DK. Incidence, mortality, and prognostic factors of small cell carcinoma of the cervix. Obstet Gynecol 2008; 111 (06) 1394-1402
    CrossrefPubMedGoogle Scholar